P538: FAST-TRACK MEASURABLE RESIDUAL DISEASE DETECTION BY MULTIPARAMETRIC FLOW CYTOMETRY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
Maximilian Roehnert(University Hospital Carl Gustav Carus), Uta Oelschlaegel(University Hospital Carl Gustav Carus), Philipp Ensel(University Hospital Carl Gustav Carus), Jonas Schadt(University Hospital Carl Gustav Carus), Christoph Roellig(University Hospital Carl Gustav Carus), Richard F. Schlenk(German Cancer Research Center), Friedrich Stoelzel(University Hospital Carl Gustav Carus), Martin Bornhaueser(University Hospital Carl Gustav Carus), Johannes Schetelig(University Hospital Carl Gustav Carus), Malte von Bonin(Städtisches Klinikum Dresden), Michael Krämer(University Hospital Carl Gustav Carus)
Cited by 0
Related Papers
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML
|Blood|2010|485
<i>RUNX1</i>Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group
|Journal of Clinical Oncology|2011|450